LYMPHOMA

This study tested a combination of two drugs, isatuximab and cemiplimab, in people with certain types of lymphoma that had come back or not responded to treatment. The goal was to find a safe dose and see if the combination could shrink tumors. The trial was stopped early, so res…

This study tested whether the drug ofatumumab could control any remaining chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after initial chemotherapy. It was designed for patients whose disease had not worsened after prior treatment. The trial was terminated…

This study looked at adding the targeted drug inotuzumab ozogamicin to standard chemotherapy before and after a stem cell transplant for people with certain blood cancers like leukemia and lymphoma. The goal was to see if it was safe and could help control the cancer. The study w…

This study tested whether giving two immunotherapy drugs (nivolumab and ipilimumab) after a stem cell transplant could help control high-risk multiple myeloma and lymphoma. It enrolled 46 adults aged 18-80. The main goal was to check safety, but the study was terminated early, so…

This study tested a combination of two drugs—pembrolizumab (a cancer immunotherapy) and CMP-001 (an injection that activates the immune system)—in 14 adults with relapsed or refractory Hodgkin or non-Hodgkin lymphoma. The goal was to find a safe dose that could shrink tumors. The…

This study tested the drug pembrolizumab in people with a fast-growing lymphoma (DLBCL) that had come back or not responded to other treatments. Only patients whose cancer had a specific genetic change in PD-L1 were included. The study was stopped early after enrolling just 5 par…

This study tested a combination of two drugs, umbralisib and rituximab, as the first treatment for people with follicular lymphoma or marginal zone lymphoma. The goal was to see how many patients had their cancer completely disappear. The study was stopped early and included 18 a…

This study tested a digital app that appears on the phone's lock screen to encourage physical activity in cancer survivors. Participants used the app for 3 months and wore a Fitbit to track activity. The goal was to see if the app could increase exercise and improve blood vessel …

This study tested a sensory rehabilitation program for people who lost their sense of smell or taste after chemotherapy for blood cancers like multiple myeloma or lymphoma. The program aimed to improve these senses and boost quality of life, nutrition, and mental well-being. Only…

This research registry looks at the health, well-being, and needs of people who survived cancer as young adults (diagnosed between ages 18 and 39). It tracks levels of anxiety, depression, social support, and financial distress by having participants fill out online surveys every…

This study tested whether using special imaging during surgery could help doctors more accurately and safely biopsy lymph nodes in the abdomen. It involved 11 adults with suspected lymphoma or swollen lymph nodes. The approach used real-time image guidance to target the biopsy, a…